The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride

Regulatory Toxicology and Pharmacology

Volumn 32, Issue 2, 2000, Pages 144-155

  Delic, Julian I ^a   Lilly, Patrick D ^b   MacDonald, Alex J ^c   Loizou, George D ^c  

^a HEALTH AND SAFETY EXECUTIVE   (United Kingdom)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c HEALTH AND SAFETY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CHLOROFORM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG METABOLISM; FEMALE; MATHEMATICAL MODEL; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK ASSESSMENT; RISK FACTOR; SYSTEM ANALYSIS; UNITED KINGDOM; WORK ENVIRONMENT; WORKPLACE;

ANIMALIA; RODENTIA;

EID: 0033751510     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.2000.1419     Document Type: Article

References (39)

1. Physiological pharmacokinetics and cancer risk assessment
2. Physiologically based pharmacokinetics and cancer risk assessment
3. Metabolism of chloroform by cytochrome P450 is required for induction of toxicity in the liver and kidney of male B6C3F1 mice
4. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene
5. Development of a physiologically based pharmacokinetic model for chloroform
6. Regulatory history and experimental support of uncertainty factors
7. The uncertainty factor in the setting of occupational exposure standards
8. Toxic effects of chemicals: Difficulties in extrapolating data from animals to man
9. Partition coefficients of low-molecular weight volatile chemicals in various liquids and tissues
10. Chloroform toxicity in mice: Correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules
11. Interspecies scaling and comparisons in drug development and toxicokinetics
12. Susceptibility of male and female mice to the nephrotoxic and hepatotoxic properties of chlorinated hydrocarbons
13. Physiologically based pharmacokinetic modeling of chemical mixtures
14. Lack of chloroform-induced DNA repair in vitro and in vivo in hepatocytes of female B6C3F1 mice
15. A 90-day chloroform inhalation study in female and male B6C3F1 mice: Implications for cancer risk assessment
16. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vs ad libitum in drinking water
17. Toxicity and cell proliferation in the liver, kidneys and nasal passages of female F-344 rats, induced by chloroform administered by gavage
18. Induced regenerative cell proliferation in livers and kidneys of male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water
19. Estimation of the dermal absorption of m-xylene vapor in humans using breath sampling and physiologically based pharmacokinetic analysis
20. Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat
21. Occupational exposure limits for airborne chemicals in Britain
22. A physiologically based pharmacokinetic model for inhaled carbon tetrachloride
23. Phosgene: A metabolite of chloroform
24. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans
25. Development of physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane
26. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling
27. Data-derived safety factors for the evaluation of food additives and environmental contaminants
28. Patterns of chloroform-induced regenerative cell proliferation in BDF1 mice correlate with organ specificity and dose-responses of tumor formation
29. A 90 day chloroform inhalation study in F-344 rats: Profile of toxicity and relevance to cancer studies
30. Acute intoxication with trichloroethene: Clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage
31. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation
32. Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): A computational method
33. PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic and chronic inhalation exposure
34. Dose- and route-dependent alterations in metabolism and toxicity of chemical compounds in ethanol-treated rats: Difference between highly (chloroform) and poorly (carbon tetrachloride) metabolized hepatotoxic compounds
35. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression